Related Experiment Video
Updated: Jul 12, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Chronic inflammatory demyelinating polyneuropathy associated with intestinal tuberculosis.
Vui Heng Chong1, Thykkoottathyl Pappy Joseph, Pemasiri Upali Telisinghe
1Gastroenterology Unit, Department of Medicine, Raja Isteri Pengiran Anak Saleha Hospital, Bandar Seri Begawan, Brunei Darussalam. chongvuih@yahoo.co.uk
Chronic inflammatory demyelinating polyneuropathy (CIDP), an immune-mediated disorder, can be triggered by infections like tuberculosis (TB). Treating TB significantly improved CIDP symptoms, underscoring the importance of considering TB in neurological cases.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neurological disorder with variable presentations, potentially leading to significant morbidity if diagnosis and treatment are delayed.
- While often relapsing-remitting, CIDP can present rapidly and is associated with various infective and non-infective causes.
Observation:
- A case of CIDP presenting with progressive motor weakness and weight loss was observed.
- The patient's symptoms showed partial improvement with standard treatments like intravenous immunoglobulin and steroids.
Findings:
- The patient experienced significant improvement only after initiating anti-tuberculosis (TB) therapy for concurrent ileocecal TB.
- A relapse of CIDP symptoms occurred when anti-TB treatment was prematurely stopped while immunosuppressive therapy continued.
- Resuming anti-TB therapy led to a good recovery, indicating a strong link between TB and CIDP in this case.
Implications:
- This case highlights the critical need to consider tuberculosis (TB) as a potential underlying etiology in patients presenting with neurological disorders like CIDP.
- Early diagnosis and appropriate treatment of concurrent infections, such as TB, are crucial for managing CIDP effectively.
- The findings suggest that TB-associated CIDP may require specific anti-infective treatment alongside standard immunomodulatory therapies.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Inflammatory Bowel Disease III: Crohn's Disease
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis